CRINETICS PHARMACEUTICALS
Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.
CRINETICS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.crinetics.com
Total Employee:
101+
Status:
Active
Contact:
(760) 274-6963
Total Funding:
446 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Crinetics Pharmaceuticals
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Crinetics Pharmaceuticals
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Crinetics Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Crinetics Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Crinetics Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Crinetics Pharmaceuticals
5AM Ventures
5AM Ventures investment in Series B - Crinetics Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series B - Crinetics Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series B - Crinetics Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Crinetics Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.crinetics.com Semrush global rank: 2.41 M Semrush visits lastest month: 7.51 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Crinetics Pharmaceuticals"
Crinetics Pharmaceuticals - Crunchbase Company …
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.See details»
Corporate Presentation - ir.crinetics.com
Safe Harbor Statement This presentation contains forward-looking statements. Crinetics Pharmaceuticals, Inc. (“Crinetics,” the “company,” “we,” “us,” or “our”) cautions you that all …See details»
From Startup to NASDAQ – The Story of San Diego …
By Amy Duncan, Goldfish Consulting, Inc. Of the six San Diego life science initial public offerings (IPOs) in 2018, Crinetics Pharmaceuticals (CRNX) raised the most money at $117 million 1. Started by four scientists in 2008 and now …See details»
Crinetics Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Crinetics’ lead development candidate, paltusotine, is the first investigational once-daily, oral, selective somatostatin receptor type 2 (SST2) nonpeptide agonist that is in clinical …See details»
About Crinetics Pharmaceuticals (CRNX) San Diego …
Crinetics was founded by a team of scientists in drug discovery and development who are dedicated to creating new therapies for rare endocrine disease patients.See details»
Org Chart Crinetics Pharmaceuticals - The Official Board
The org chart of Crinetics Pharmaceuticals contains its 24 main executives including Scott Struthers, Tobin Schilke, Jeff Knight and Darren Allender.See details»
Crinetics Pharmaceuticals - Corporate Governance
Crinetics Pharmaceuticals (CRNX) Investor Relations – Press releases, events, financials / SEC filings, corporate governance, FAQ, stock quote chart, contact information for stock holders, …See details»
Crinetics Pharmaceuticals - VentureRadar
Crinetics was founded by a team of scientists with a proven track record of endocrine drug discovery and development to create important new therapeutic options for endocrinologists …See details»
Crinetics - 2025 Company Profile, Funding & Competitors - Tracxn
May 2, 2025 Crinetics is a public company based in San Diego (United States), founded in 2008 by Scott Struthers. It operates as a Developer of therapies for the treatment of endocrine …See details»
Crinetics Pharmaceuticals - Investor FAQ
Crinetics Pharmaceuticals (CRNX) Investor Relations – Press releases, events, financials / SEC filings, corporate governance, FAQ, stock quote chart, contact information for stock holders, …See details»
Crinetics Pharmaceuticals (NASDAQ: CRNX)Strategic Overview and ...
Feb 20, 2025 Crinetics Pharmaceuticals (NASDAQ: CRNX) has emerged as a leading clinical-stage biopharmaceutical company focused on addressing unmet medical needs in …See details»
Crinetics Pharmaceuticals - Crinetics Pharmaceuticals Reports First ...
1 day ago About Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of …See details»
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial …
Aug 8, 2024 Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine …See details»
Crinetics Pharmaceuticals - Crinetics Pharmaceuticals to Showcase ...
Crinetics is committed to the neuroendocrine tumor community, and we are now utilizing our world class drug discovery and development capabilities to support people living with both functional …See details»
News - Crinetics
Apr 11, 2025 Crinetics granted non-qualified stock option awards to purchase an aggregate of 95,675 shares of its common stock to fifteen new non-executive employees and 80,000 to one …See details»
Crinetics Pharmaceuticals Announces Pricing of Upsized Public …
SAN DIEGO – October 8, 2024 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization …See details»
Drug Development Research Pipeline | Crinetics
Crinetics is developing paltusotine for the treatment of #acromegaly. It establishes a new class of oral, selective, nonpeptide, somatostatin receptor type 2 (SST2) agonist.See details»
Crinetics Pharmaceuticals Reports First Quarter 2025 ... - BioSpace
12 hours ago Crinetics’ lead development candidate, paltusotine, is the first investigational once-daily, oral, selective somatostatin receptor type 2 (SST2) nonpeptide agonist that is in clinical …See details»
Crinetics Pharmaceuticals Inc (CRNX) Q1 2025 Earnings Call …
4 hours ago Crinetics Pharmaceuticals Inc (CRNX) outlines its robust pipeline and financial strength amid rising expenses and strategic global launch plans.See details»
Crinetics Pharmaceuticals - Contacts, Employees, Board Members ...
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.See details»